To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
6 Current news of Genizon BioSciencesrss
Genizon BioSciences Inc. and Neuropsychiatrie, Decouverte & Innovation Inc. (NDEI) announced an agreement under which the groups will collaborate to enhance and potentially add to discoveries made by Genizon early this year in a genome-wide association study of schizophrenia. Genizon's study ...
Genizon BioSciences announced publication in Proceedings of the National Academy of Sciences of four novel loci in Crohn's disease, in addition to confirmation of three known Crohn's disease genes. These discoveries are derived from a genome-wide association study in the Quebec Founder ...
Collaboration using "Quebec Founder Population" in genome-wide association studies to be used to develop diagnostics
Genizon BioSciences announced a license and collaboration agreement with Pfizer Inc. for diagnostic rights to Genizon's discovery programs in Alzheimer's disease, attention deficit hyperactivity disorder and endometriosis. Genizon retains therapeutic rights. Under the terms of the agreement, ...
Genizon BioSciences has become the first commercial organization to achieve certification under the new Certified Service Provider (CSPro) Program from Illumina, Inc. This certification assures compliance with the highest quality standards for Genizon's new genotyping services. The Illumina ...
Genizon BioSciences announced a license and collaboration agreement with Genentech, Inc. Genizon grants Genentech an exclusive license to Genizon's GeneMap of disease-associated genes generated from a whole genome association study of Crohn's disease patients from the Quebec Founder ...
Results Confirm the Power of Genizon's Platform and the Quebec Founder Population for Disease Gene Discovery
Genizon Biosciences and the Institute for Clinical Molecular Biology, University Hospital Schleswig-Holstein announced the replication of many disease gene signals for Crohn's disease, previously discovered by Genizon in the Quebec Founder Population. This replication further confirms the ...